Neuroinflammation in comorbid depression in Alzheimer's disease: A pilot study using post-mortem brain tissue

Area of Science:

• Neuroscience
• Immunology
• Psychiatry

Background:

• Comorbid depression and Alzheimer's disease (AD) worsen prognosis.
• Neuroinflammation is implicated in both conditions, but research often uses peripheral markers.
• Brain tissue immune markers in co-occurring depression and AD are understudied.

Purpose of the Study:

• To investigate brain inflammatory marker differences in post-mortem tissue from AD cases with and without comorbid depression.
• To analyze microglial, endothelial, and cytokine markers directly within brain tissue.

Main Methods:

• Post-mortem brain tissue analysis from AD cases with (n=23) and without (n=25) depression.
• Immunohistochemistry for microglial markers (Iba1, P2RY12, CD64, CD68).
• ELISA for endothelial markers (ICAM-1, VCAM-1) and Mesoscale Discovery for cytokine levels (IFN-γ, IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70, IL-13, TNF-α).

Main Results:

• AD cases with depression showed increased Interleukin-4 (IL-4) in the superior frontal gyrus.
• Increased Tumor Necrosis Factor-alpha (TNFα) and IL-12p70 were found in the insula of AD cases with depression.
• No significant differences in other inflammatory markers, including microglial and endothelial markers, were observed between groups.

Conclusions:

• Comorbid depression in AD is associated with specific regional increases in certain cytokines (IL-4, TNFα, IL-12p70) within the brain.
• These findings suggest distinct neuroinflammatory profiles depending on the brain region.
• Larger studies are needed to confirm region-specific immune alterations and their clinical relevance.